Larvol Delta - Benefits-of-primary-prophylaxis-with-letermovir-in-patients-after-allogeneic-hematopoietic-stem-cell-transplantation-for-hematologic-malignancies

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/40406960

Agata Wieczorkiewicz-Kabut; Anna Armatys; Grzegorz Helbig; Izabela Noster

May 23, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next